Ryvu Therapeutics Statistics

Total Valuation

WSE:RVU has a market cap or net worth of PLN 700.54 million. The enterprise value is 614.66 million.

Market Cap	700.54M
Enterprise Value	614.66M

Important Dates

The next estimated earnings date is Friday, September 5, 2025.

Earnings Date	Sep 5, 2025
Ex-Dividend Date	n/a

Share Statistics

WSE:RVU has 23.12 million shares outstanding. The number of shares has decreased by -0.01% in one year.

Current Share Class	19.07M
Shares Outstanding	23.12M
Shares Change (YoY)	-0.01%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	23.80%
Owned by Institutions (%)	52.82%
Float	15.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.18
PB Ratio	5.86
P/TBV Ratio	6.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.24
EV / Sales	6.30
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.51

Financial Position

The company has a current ratio of 3.17, with a Debt / Equity ratio of 0.80.

Current Ratio	3.17
Quick Ratio	2.88
Debt / Equity	0.80
Debt / EBITDA	n/a
Debt / FCF	-0.71
Interest Coverage	-24.64

Financial Efficiency

Return on equity (ROE) is -74.50% and return on invested capital (ROIC) is -31.81%.

Return on Equity (ROE)	-74.50%
Return on Assets (ROA)	-21.99%
Return on Invested Capital (ROIC)	-31.81%
Return on Capital Employed (ROCE)	-51.34%
Revenue Per Employee	297,466
Profits Per Employee	-357,659
Employee Count	328
Asset Turnover	0.27
Inventory Turnover	11.08

Taxes

In the past 12 months, WSE:RVU has paid 288,000 in taxes.

Income Tax	288,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.92% in the last 52 weeks. The beta is 0.61, so WSE:RVU's price volatility has been lower than the market average.

Beta (5Y)	0.61
52-Week Price Change	-39.92%
50-Day Moving Average	31.01
200-Day Moving Average	36.50
Relative Strength Index (RSI)	49.19
Average Volume (20 Days)	40,410

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, WSE:RVU had revenue of PLN 97.57 million and -117.31 million in losses. Loss per share was -5.12.

Revenue	97.57M
Gross Profit	79.13M
Operating Income	-127.27M
Pretax Income	-117.02M
Net Income	-117.31M
EBITDA	-117.40M
EBIT	-127.27M
Loss Per Share	-5.12

Full Income Statement

Balance Sheet

The company has 182.09 million in cash and 96.21 million in debt, giving a net cash position of 85.88 million or 3.71 per share.

Cash & Cash Equivalents	182.09M
Total Debt	96.21M
Net Cash	85.88M
Net Cash Per Share	3.71
Equity (Book Value)	119.60M
Book Value Per Share	5.17
Working Capital	153.56M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -130.43 million and capital expenditures -5.86 million, giving a free cash flow of -136.28 million.

Operating Cash Flow	-130.43M
Capital Expenditures	-5.86M
Free Cash Flow	-136.28M
FCF Per Share	-5.89

Full Cash Flow Statement

Margins

Gross margin is 81.10%, with operating and profit margins of -130.45% and -120.23%.

Gross Margin	81.10%
Operating Margin	-130.45%
Pretax Margin	-119.94%
Profit Margin	-120.23%
EBITDA Margin	-120.32%
EBIT Margin	-130.45%
FCF Margin	n/a

Dividends & Yields

WSE:RVU does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.01%
Shareholder Yield	n/a
Earnings Yield	-16.75%
FCF Yield	-19.45%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

WSE:RVU has an Altman Z-Score of 2.07 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.07
Piotroski F-Score	3